📄 Direct examination of Roger Martz (part 3) — Tuesday, July 25, 1995
Address:
C:\DEPT103\CRIMINAL\1995\JUL\25\DIRECT-EXAMINATION-OF-ROGER-MA.DOC
TRIAL
▲ Day 121 of 167

Direct examination of Roger Martz (part 3)

Witness: Roger Martz
Examiner: Robert Blasier
Called by: Defense • Date: Tuesday, July 25, 1995 • Utterances: 727
Defense attorney Robert Blasier cross-examines FBI Agent Roger Martz about his EDTA testing of blood from the sock (Q206/Q207) and back gate, methodically exposing weaknesses in his methodology including mixing samples, choosing the less-sensitive negative ion mode first, never reading the Quantico validation study, failing to validate extraction efficiency, and making untested assumptions about environmental factors. Martz repeatedly insists EDTA was not present in amounts consistent with preserved blood, while Blasier demonstrates that Martz's controls were inadequate and his conclusions were assumed rather than proven.
1 MR. BLASIER:

Thank you, your Honor.

2 MR. BLASIER:

Agent Martz, at the break did I ask you to take a look at those 250 parts per million to compare the areas as you indicated?

3 MR. MARTZ:

That's correct.

4 MR. BLASIER:

What is the difference in the areas of the 250 parts per million charts that you ran on the 22nd?

5 MR. MARTZ:

It is about a four-fold difference.

6 MR. BLASIER:

Okay. You agree that the 50 parts per million, you knew that that is exactly what it was because you had prepared known EDTA in that concentration to put in your machine?

7 MR. MARTZ:

That's correct.

8 MR. BLASIER:

And when you put it through the second time and got a four-fold difference in your area output, it was still the same, 50 parts per million?

9 MR. MARTZ:

Yes.

10 MR. BLASIER:

Now, would you agree that the substance that you found that had the consistent retention time, the parent ion and the daughter ion, that in your opinion the quantities that you found are in the parts per million range?

11 MR. MARTZ:

That would be the most, yes.

12 MR. BLASIER:

Okay. Which is--correct me if I am wrong--a thousand times more than the parts per billion range?

13 MR. MARTZ:

That's correct.

14 MR. BLASIER:

Now, I want to ask you some questions about the technique that you used at the beginning of your testing. Do you have that in mind?

15 MR. MARTZ:

Yes.

16 MR. BLASIER:

When you got the stains in this case, when you got Q206 and Q207--actually, you assigned those numbers, didn't you?

17 MR. MARTZ:

Well, they were actually assigned by special agent Doug Deedrick.

18 MR. BLASIER:

That is an FBI; not an LAPD number?

19 MR. MARTZ:

Right. That's correct.

20 MR. BLASIER:

When you got those samples, did I hear you say this morning that you mixed those two together for your first series of tests?

21 MR. MARTZ:

Yes, that's correct.

22 MR. BLASIER:

And you did not know what Q207 was?

23 MR. MARTZ:

I knew it was from the sock and obviously it was blood-stained, but I didn't specifically know that it was cut out of that area. I mean, it was logical to assume that, but I didn't know that for a fact.

24 MR. BLASIER:

So you, as part of the first steps of your tests, combined two unknown samples, the source of which you didn't know?

25 MR. MARTZ:

Well, I knew they were both from the sock and I knew they were both bloodstains from the sock and my object was to determine whether or not there was EDTA present on the sock, so I combined the two to see whether or not EDTA was present on either of those particular cuttings and I took that into account by using twice as much of that particular sample as I did from the control that I prepared.

26 MR. BLASIER:

So you used twice as much in that run and that was using A--the negative ion mode that we talked about a little bit this morning?

27 MR. MARTZ:

That's correct.

28 MR. BLASIER:

The less sensitive testing?

29 MR. MARTZ:

The one that is much more specific. In this particular case it was less sensitive, but you got to remember here it has a lot more specificity and that is why I used it again. Negative ion mass spec is a very sensitive technique and in order to identify the EDTA present it has to react with iron. EDTA is a chelating agent. So I wanted to use a very specific test and that is why I chose that test on that day, because I not only had to have a compound with a particular molecular weight, it had to react with iron in order to give these results. And the only ones that gave results on that particular day were the controls that I prepared.

30 MR. BLASIER:

Now, but--but you determined yourself by your own experimentation that that was one/tenth as sensitive as the positive ion moved that we have been talking about?

31 MR. MARTZ:

It had less sensitivity, but sensitivity was not my problem. What I was asked to do was to determine whether or not the stains were EDTA-preserved or not preserved. I was able to answer that question in the negative ion mode very easily. These stains were not from preserved blood.

32 MR. BLASIER:

Well, we will talk about that later. When you ran the positive ion mode the next day, the more--the test that will detect the ions more sensitively than the one you did the day before, would you agree with that?

33 MR. MARTZ:

It was more sensitive, but sensitivity was not an issue. Specificity was my issue. I wanted to determine whether or not EDTA was present and if it was I wanted to make sure I could identify it, and as I mentioned, it was not present.

34 MR. BLASIER:

So you weren't concerned with whether it was there or not when you did the negative ion mode?

35 MR. MARTZ:

No. I was asked to determine whether or not EDTA was present and it was very easy to do in the negative ion mode. I was able to determine on the first day that EDTA was not present on those particular stains and those stains did not come from preserved blood.

36 MR. BLASIER:

Were you able to determine with the negative mode that there wasn't EDTA on those stains?

37 MR. MARTZ:

There was not EDTA present in the amount that you would find in preserved blood.

38 MR. BLASIER:

Agent--

39 MR. MARTZ:

I proved that on the first day.

40 MR. BLASIER:

Agent Martz, please listen to my question. Were you able to determine with the negative ion mode that there was no EDTA on those stains?

41 MR. MARTZ:

I was not able to identify any EDTA on those stains.

42 MR. BLASIER:

Were you able to rule out the possibility that there was EDTA on those stains with your negative ion mode?

43 MR. MARTZ:

Yes. In my opinion EDTA was not present on those stains.

44 MR. BLASIER:

All right. When you did your testing the next day with a positive ion mode and found what looks like EDTA, where do you think it came from?

45 MR. MARTZ:

Well, you got to remember here, everyone is saying that I founded EDTA. I have never said that and I don't believe Dr. Rieders ever said that. There was indication that EDTA could have been present. There is a lot of other explanations for the ions that I got on the first day. I am not convinced that EDTA is present on that sock and I want to make that perfectly clear. There are many possibilities for those ion counts that I got. One is it could be from another compound that had similar results. That is why I performed the daughter ion experiment, to determine whether or not EDTA was present. I was convinced that EDTA was not present in those samples.

46 MR. BLASIER:

So you had made up your mind as to what you were going to find before you did the test?

KEY QUOTE
47 MR. MARTZ:

That is not correct.

48 MR. BLASIER:

Okay.

49 MR. MARTZ:

I was asked to determine whether or not those bloodstains came from preserved blood and those bloodstains did not come from preserved blood. I was able to prove that on the first day.

50 MR. BLASIER:

What you saw in that bloodstain, both bloodstains the second day, you didn't see the first day, did you?

51 MR. MARTZ:

No. It was a completely different technique as I mentioned. In the negative ion mode the EDTA must react with iron.

52 MR. BLASIER:

Agent Martz--

53 MR. MARTZ:

The second day when I ran the test all I was looking for was a 293 ion and a 162. Iron was not a factor.

54 THE COURT:

Next question.

55 MR. MARTZ:

So the possibility exists--

56 THE COURT:

Hold on. Next question.

57 MR. BLASIER:

Agent, did you add anything to the samples from day one to day two?

58 MR. MARTZ:

Yes.

59 MR. BLASIER:

Did you added EDTA?

60 MR. MARTZ:

No, I added water.

61 MR. BLASIER:

Did you add--does water give you a pattern like EDTA?

62 MR. MARTZ:

As I told you, I did not identify EDTA in any of the samples on any day.

63 MR. BLASIER:

All right. Lets talk in terms of the 293 parent ion which EDTA has and the 160 daughter ion which EDTA had. Do you have that in mind?

64 MR. MARTZ:

Yes.

65 MR. BLASIER:

Did you add anything that had a parent ion of 293 and a daughter ion of 160 between day one and day two?

66 MR. MARTZ:

Well, I don't quite understand that question. Of course I didn't, but the fact of the matter is on the first day I didn't even look for these ions.

67 MR. BLASIER:

Well your Honor, I move to strike everything except "Of course I didn't."

68 THE COURT:

Sustained. The answer is stricken as being nonresponsive.

69 MR. BLASIER:

Are you saying that that 293 parent ion and the 160 daughter ion weren't there the first day?

70 MR. MARTZ:

I didn't look for them the first day.

71 MR. BLASIER:

Then you don't now whether they were there or not, do you?

72 MR. MARTZ:

Well, it is difficult to determine if I didn't look for them.

73 MR. BLASIER:

The second day you found them, didn't you?

74 MR. MARTZ:

The second day--

75 MS. CLARK:

Objection, this is argumentative.

76 THE COURT:

Sustained. Rephrase the question.

77 MR. BLASIER:

Did you find them the second day?

78 MR. MARTZ:

I detected both ion 162 and 293 on the second day because the experiment that I performed looked for those various ions.

79 MR. BLASIER:

Now, let me ask you this: Is your reason for saying that what you found, even though it has consistent retention time, consistent parent ion, consistent daughter ion, that the reason you are unwilling to say that that is EDTA is because you couldn't find the 132 daughter ion?

80 MR. MARTZ:

No, I didn't say that at all. The reason that I'm saying that it is not EDTA is several-fold. I conducted many experiments over several days. The first day I looked for EDTA in the negative ion mode. It was not present. On another day, the 28th, I looked for EDTA on another test in HPLC which was completely different testing than any of the other days. EDTA was not present on the sock or on the gate, so I have two tests that showed no EDTA is present. I have another test on another day which has ions that are similar or the same as EDTA. In order for me to identify EDTA, I have to have what's called a full daughter spectrum. When you just looked at several ions, you can make mistakes. Those mistakes have been made and because mistakes like that have been made, procedures have been changed. In order for me to positively identify a chemical to the exclusion of all others I need to have a full daughter spectrum, and in order to do that I have to set the scan, the instruments the way that I did. I was not able to identify EDTA in those particular stains.

81 MR. BLASIER:

Agent Martz, you agree that you did detect at the appropriate retention time the 293 parent ion, the 160 daughter ion on day two?

82 MR. MARTZ:

Well, you are making a great deal of the retention time.

83 MR. BLASIER:

Your Honor, move to strike.

84 THE COURT:

Sustained.

85 MR. BLASIER:

You found that, didn't you, 293, the 160, at the appropriate retention time?

86 MR. MARTZ:

Umm, that's correct.

87 MR. BLASIER:

Have you identified anything other than EDTA?

88 MS. CLARK:

Objection. That assumes a fact not in evidence and contrary to the testimony that it is an appropriate retention time, your Honor.

89 THE COURT:

Overruled. Overruled.

90 MR. BLASIER:

Have you determined any compound--have you located or identified any compound other than EDTA that accounts for your findings?

91 MR. MARTZ:

I was just faxed another copy of another chromatogram that could possibly give similar results that I just got several minutes ago.

KEY QUOTE
92 MR. BLASIER:

Okay. Do you know what that is?

93 MR. MARTZ:

Yes. I can get it for you if you would like.

94 MR. BLASIER:

What is it?

95 MR. MARTZ:

It is a steroid type chemical--it is right there.

96 MR. BLASIER:

What method was used to perform this chromatography or mass spec?

97 MR. MARTZ:

Well, that particular chromatography was probably gas chromatography and the mass spec type was electron impact.

98 MR. BLASIER:

So that is a different method also, isn't it?

99 MR. MARTZ:

Well--

100 MR. BLASIER:

Agent Martz, that is a different method?

101 MR. MARTZ:

Well, because mass spectrometry is a technique that I used for ions and that is mass spectrometry and you can make certain assumptions in mass spectrometry when you are dealing with ions. We are dealing with two ions here. That is not very many. This particular compound and many other compounds will have those two ions.

102 MR. BLASIER:

When you found what you did find, whether it is EDTA or something that just looks like EDTA, did you advise the Prosecution of what you had found?

103 MR. MARTZ:

I had prepared a report, yes.

104 MR. BLASIER:

And by the way, in your report--well, let me rephrase. How soon after you got the charts that we have seen here with the peaks at the appropriate times, parent and daughter ion, did you tell the Prosecution that you had found that?

105 MR. MARTZ:

Umm--

106 MS. CLARK:

Your Honor, again object to the question.

107 THE COURT:

Overruled.

108 MR. MARTZ:

I believe it was sometime the end of February, early March. I don't have the exact date.

109 MR. BLASIER:

Did they ever ask you to try and find what that might be, other than EDTA?

110 MR. MARTZ:

No. I mean, it was not necessary because I had already answered the question, the fact that those stains did not come from preserved blood. There was no reason to try to determine what those ions came from.

111 MR. BLASIER:

But from February until this morning or last night, you haven't tried to find a compound that explains your findings, have you?

112 MR. MARTZ:

Yes, I have, because I believe that my data has been misinterpreted by somebody else and I wanted to prove that.

113 MR. BLASIER:

I want to ask you some questions about your--oh, incidentally, you said that you used twice as much on day one of the Q206/Q207 mixture than you used the next day?

114 MR. MARTZ:

That's correct.

115 MR. BLASIER:

So you used half as much sample when you used the more sensitive test?

116 MR. MARTZ:

Well, I--in every case that I did this--

117 MR. BLASIER:

Your Honor, move to strike as nonresponsive.

118 THE COURT:

Sustained.

119 MR. BLASIER:

You used half as much with the more sensitive test?

120 MR. MARTZ:

I used half as much of the 206 versus 207 on the 22nd as I did on the 19th.

121 MR. BLASIER:

Would you agree that if there had been EDTA in your mixture of Q206 and Q207 there would be one-half as much in the test that you ran the next day, the more sensitive test?

122 MR. MARTZ:

Not necessarily. I mean, as we have mentioned, the quantitation is not perfect on this instrument and I did not design this technique to precisely quantitate how much EDTA was present or if wasn't present. I was trying to determine whether it was there or not from preserved blood, so twice as much would not make that much of a difference in the results that I got.

123 MR. BLASIER:

Did you run any experiments with different amounts--well, let me rephrase that. Would you agree that in order to make any kind of an assessment of concentration of how much you get at the end of the process, you have to know how much you start with?

124 MR. MARTZ:

Umm, sure, yes.

125 MR. BLASIER:

Now, the evidence that you received--let's talk about the back gate first. That was in the form of what?

126 MR. MARTZ:

It was blood that was I guess a cotton swab or some type of a gauze material was used to absorb the blood off of the back gate.

127 MR. BLASIER:

Well, do you know--do you know how that was taken off the back gate?

128 MR. MARTZ:

No, I don't know, but logically it had to have been dissolved in order to be--

129 MR. BLASIER:

Did you--

130 MR. MARTZ:

--saturated onto the cloth material.

131 MR. BLASIER:

Did you make any effort to find out how that had been removed from the back gate?

132 MR. MARTZ:

No, I did not.

133 MR. BLASIER:

Did you think that the in manner which it was removed from the back gate might have some influence on how much blood actually got onto that?

134 MR. MARTZ:

It was my opinion that that was very saturated, that piece of gauze. It was a very saturated bloodstain on that piece of gauze.

135 MR. BLASIER:

Agent Martz, were you concerned about the fact that different methods of removing that stain might result in different amounts of blood?

136 MR. MARTZ:

No. The only thing I was concerned about is whether or not the bloodstain was larger than the material that was collected, because I was using my technique by the size of the bloodstain and--

137 MR. BLASIER:

Did it come to you--

138 MR. MARTZ:

Can I continue answering the question?

139 MR. BLASIER:

I'm sorry.

140 THE COURT:

Go ahead.

141 MR. MARTZ:

And I wanted to be satisfied that the bloodstain was at least as large as that cotton swab. And by asking, I was able to determine that the bloodstain was larger than the cotton swab itself and that was my main concern.

142 MR. BLASIER:

By asking?

143 MR. MARTZ:

Yes. I had asked how large the bloodstain was and I was told that it was larger than the cotton swab.

144 MR. BLASIER:

How large what bloodstain was?

145 MR. MARTZ:

On the gate.

146 MR. BLASIER:

Did you ever ask how much of that bloodstain had been removed and put on whatever you got it on?

147 MR. MARTZ:

No.

148 MR. BLASIER:

Now, did you get it on a swab or on a swatch?

149 MR. MARTZ:

It was a very small swatch.

150 MR. BLASIER:

Did you ever ask how many other swatches had been made from that blood drop?

151 MR. MARTZ:

No, I did not. I didn't feel it was necessary. When I looked at that blood swatch I could see that it was thoroughly saturated with blood and that was my concern.

152 MR. BLASIER:

Do you have a spectrophotometer in your lab?

153 MR. MARTZ:

Yes.

154 MR. BLASIER:

Is that an acceptable means of determining how much you might have of blood in a solution?

155 MR. MARTZ:

Well, it is an acceptable means I think of determining how much hemoglobin is present and from that you could possibly calculate how much blood was present.

156 MR. BLASIER:

Did you use any method at all, other than just looking at it, to try and tell how much blood was in this swatch?

157 MR. MARTZ:

Yes.

158 MR. BLASIER:

What?

159 MR. MARTZ:

I did a visual examination also of the extract after I extracted the blood with the water and I got a very intense red color, which indicated to me that it was concentrated blood, and also I did a testing to prove that it was--or to indicate that it was blood.

160 MR. BLASIER:

Did the testing that you did, does that establish quantity at all?

161 MR. MARTZ:

Well, I think it does somewhat. I mean, I could visually see the blood on the swatch and I could visually see the color of the extract that I performed.

162 MR. BLASIER:

Agent Martz, is it your testimony that you can tell with any precision how much blood is in a solution by looking at it?

163 MR. MARTZ:

For this particular case, I think that it is, because EDTA in preserved blood is at least a thousand parts per million. If it is present in humans, at a part per million, which we have now established, that is a thousand-fold difference and I don't believe that any technique that I could have used could have been off by a thousand percent. I mean, I didn't need to be that accurate in order to determine whether or not the bloodstains were from preserved blood or from non-preserved blood. I was very, very careful in the sizes that I cut and I always made sure that I took more sample from the questioned samples than the control samples. That is why I very carefully looked at the color as I extracted and I was convinced that I had at least as much blood on the control areas as I did on the questioned areas or as on the--I had at least as much on the questioned areas as I did on the control areas. I was very, very careful in this analysis.

164 MR. BLASIER:

Did I understand you to say that you weren't concerned with the quantity of blood that you got on the swatch?

165 MR. MARTZ:

I was concerned with the quantity. I wanted to make sure that I had at least as much blood on the questioned areas as I did on the control areas and I was convinced that I did. I was concerned, but even if there was a mistake of one, two, fifty, a hundred percent, I mean, I would still be able to answer the question whether it was from preserved blood or non-preserved blood. I was concerned. Yes, I was concerned.

166 MR. BLASIER:

Did you perform any tests, other than just looking at it, that was designed to find out how much blood was in the swatch that you started with?

167 MR. MARTZ:

I did a presumptive test on the blood and I got similar colors which would indicate I had similar concentrations of blood.

168 MR. BLASIER:

What presumptive test did you use?

169 MR. MARTZ:

I used the phenolphthalein.

170 MR. BLASIER:

Is that considered a quantitative test for blood?

171 MR. MARTZ:

I mean not necessarily, but you do have a color reaction just like you have a color of blood. And everything I did, I did to make sure that I had at least as much blood on the questioned areas as I did on the control areas.

172 MR. BLASIER:

Now, the stain from the sock, did you do any kind of testing on that, other than looking at it to determine how much blood you got from the sock?

173 MR. MARTZ:

As I mentioned earlier, yes, I did other tests.

174 MR. BLASIER:

Anything other than what you've already told us?

175 MR. MARTZ:

No.

176 MR. BLASIER:

Did you examine the swatch material that you got on the back gate under the microscope?

177 MR. MARTZ:

No, I did not.

178 MR. BLASIER:

The sample that you prepared, your known samples from the reference tubes that we looked at, where did you get the swatches to do this?

179 MR. MARTZ:

Well, on the sock, I actually cut a piece off of the sock because I wanted to use the same type of material, so what I had was a bloodstain on the sock, so I took the person's blood--

180 THE COURT:

Excuse me. Excuse me. Agent Martz, the question was from the reference tubes where did you get the swatches to do this; not the sock?

181 MR. MARTZ:

Well, that is the answer, your Honor. I took the sock. That is what I used.

182 MR. BLASIER:

Okay, for the sock reference. How about for the gate reference what did you use?

183 MR. MARTZ:

Well, as I was explaining, I wanted to try to make things equal, so for the stain that I produced for the sock, I took a piece of the sock. I took some of the blood of Nicole brown, which was the one suspected or the one identified as being on the sock. I placed blood onto that sock. I let it dry naturally.

184 THE COURT:

All right. Agent Martz, the question was what did you do to prepare the sample for the gate? Not the sock; the gate?

185 MR. MARTZ:

Okay. For the gate I took a similar type of cotton swatch in the laboratory and placed blood onto that swatch.

186 MR. BLASIER:

You didn't use a swatch that came from LAPD?

187 MR. MARTZ:

No. It was--it was too small. In order to put a bloodstain onto a fabric and let it dry naturally, I was using ten microliters of blood. I needed a better size swatch. The size that they submitted to me was not large enough to do that particular test.

188 MR. BLASIER:

Is it your opinion that the amount of blood in a swatch is not determined by the kind of swatch--let me rephrase that. Is it your opinion that if you used a swatch, let's say that had four layers of gauze rather than two, that it is still going to hold the same amount of blood?

189 MR. MARTZ:

I tried to use the same type of swatch that was used in the particular case is all I can say. Whether it is two or four layers, it would make a difference as to how much it would absorb.

190 MR. BLASIER:

Agent Martz, did you ever examine the swatch you got from LAPD to determine under the microscope what kind of a swatch it was, how many layers were there?

191 MR. MARTZ:

No, I did not.

192 MR. BLASIER:

Did you ever look at your own swatch that you got from your lab to determine how many layers were in that swatch?

193 MR. MARTZ:

No, I did not.

194 MR. BLASIER:

Now, do you recall--well, let me ask you this: Your eyeball estimate or the way that you did this, what was your estimate of how much blood was on the gate swatch?

195 MR. MARTZ:

I did not estimate the amount of mood on that. What I did was to take a swatch of the same amount and prepared it similarly. I did not attempt to determine how much blood was on the swatch except for the fact that the swatch appeared to be saturated with blood.

196 MR. BLASIER:

So then you made no effort to determine how much blood was there?

197 MR. MARTZ:

Well, visually I looked at it and the swatch was saturated with blood. Like if you were bleeding and would put something to it, it would absorb the blood. The swatch absorbed the blood. It appeared to be saturated with blood.

198 MR. BLASIER:

Do you remember me asking that question when we visited together in Washington?

199 MR. MARTZ:

Not specifically. I'm sure you did, but I can't remember specifically my answer.

200 MR. BLASIER:

Do you remember telling me that you estimated the amount of blood from the back gate as two microliters?

201 MR. MARTZ:

I can't remember that, but it would be at least--I would say it was somewhere between two and five microliters would be my best guesstimate.

202 MR. BLASIER:

Do you remember me asking the same question about how much blood was on the sock stain that you cut?

203 MR. MARTZ:

I think I may have answered that. Was it 800 microliters, 200? I can't remember.

204 MR. BLASIER:

50 microliters?

205 MR. MARTZ:

50 microliters.

206 MR. BLASIER:

How much blood is there in a drop, how many microliters?

207 MR. MARTZ:

Oh, I don't know. I don't--I don't do a lot of volumes with blood. All I know is I used ten microliters and five microliters and created some stains.

208 MR. BLASIER:

Let's assume hypothetically that 50 microliters of blood is one to two drops. Do you have that assumption in mind?

209 MR. MARTZ:

Okay.

210 MR. BLASIER:

Your opinion is that there was one to two drops of blood on the cutting from the sock that you took?

211 MR. MARTZ:

Not that I took. I'm talking about the whole area of the sock that was stained. Probably 50 microliters. The area that I took was probably a couple microliters.

212 MR. BLASIER:

When you told me 50 microliters on that cutting, you misunderstood what I was asking?

213 MR. MARTZ:

Yeah. I was talking about the full stain.

214 MR. BLASIER:

Now, when you--you came up with a process that you used to extract the blood and EDTA, if there is any EDTA, from the swatch, correct, and from the sock cutting?

215 MR. MARTZ:

Yes.

216 MR. BLASIER:

What method was that?

217 MR. MARTZ:

EDTA and blood are both very soluble in water, so I extracted the materials with 25 microliters of water, let them sit for approximately 40, 45 minutes, and they were in a tube which is designed to filter out a lot of the components of blood to clean up the extract a little bit as blood contains a lot of chemicals. And then I centrifuged it for maybe five or ten minutes and the liquid past through the filter and it was collected on the bottom of the tube and that is what I used for analysis.

218 MR. BLASIER:

Were you trying to remove all the blood from the evidence?

219 MR. MARTZ:

Well, I mean I--I tried to remove as much as possible. The instrument, the way that it is set up, can take care of, you know, a very complex dirty sample, but if you shoot too much in you can clog up the system and cause excess damage to the instrument, so I tried to clean it up as much as possible.

220 MR. BLASIER:

Did you intentionally not try to remove all the blood from the swatch?

221 MR. MARTZ:

Oh, I thought you--

222 MR. BLASIER:

Did you misunderstand?

223 MR. MARTZ:

I may have misunderstood your question.

224 MR. BLASIER:

Let me ask you again.

225 MR. MARTZ:

Okay.

226 MR. BLASIER:

Did you try to remove all the blood from the swatch, the evidence swatch and the sock cutting that you made?

227 MR. MARTZ:

I treated everything the same. All I tried to do was remove the EDTA. I wasn't concerned too much with the blood. I wanted to remove EDTA from the bloodstain was my purpose.

228 MR. BLASIER:

Can I take it that you are saying, no, you didn't try to remove all the blood?

229 MR. MARTZ:

I mean, I--all I did was try to remove the EDTA from the stain for analysis.

230 MR. BLASIER:

Okay. So you tried to get all the EDTA out of there?

231 MR. MARTZ:

Exactly, yes.

232 MR. BLASIER:

And did you have any testing done to determine whether that method that you devised was effective in removing all the EDTA from a bloodstain like the ones you used?

233 MR. MARTZ:

I determined that was effective to remove EDTA from my analysis to determine whether or not the bloodstain came from a preserved tube or non-preserved tube.

234 MR. BLASIER:

Agent Martz--

235 MR. MARTZ:

Yes.

236 MR. BLASIER:

--did you do any testing to determine whether your system that you devised efficiently removed all of the EDTA from the evidence?

237 MR. MARTZ:

I didn't feel that this was necessary. All I felt was necessary was to remove the EDTA for analysis. It didn't make any difference if I got 99.9 percent of the EDTA or a hundred percent of the EDTA. I removed enough EDTA for the analysis.

238 MR. BLASIER:

Did it make any difference whether you got sixty percent of it?

239 MR. MARTZ:

It probably wouldn't have, no.

240 MR. BLASIER:

So you weren't trying to get all of the EDTA?

241 MR. MARTZ:

Certainly I was trying to get it all out.

242 MR. BLASIER:

Didn't you have some tests or weren't some validation studies performed at Quantico to answer that very question at how good your method was of pulling the EDTA out of the evidence if it was there?

243 MR. MARTZ:

If it was, I didn't understand that that was part of what they were doing.

244 MR. BLASIER:

Well, let me show you a couple of charts.

245 (Discussion held off the record between the Deputy District Attorneys.)
246 MR. BLASIER:

Your Honor, could we have these marked as--what are we up to?

247 THE CLERK:

1269.

248 MR. BLASIER:

I'm sorry, 1269?

249 THE CLERK:

Yes.

250 MR. BLASIER:

1269-A and B.

251 (Deft's 1269-A & B for id = charts)
252 MR. BLASIER:

Agent Martz, did you review the validation materials that Quantico prepared for you?

253 MR. MARTZ:

No, I did not. They were not prepared for me.

254 MR. BLASIER:

Who asked Quantico to do a validation study to validate your method?

255 MS. CLARK:

Objection.

256 MR. BLASIER:

Well, did anybody--

257 MR. MARTZ:

I don't know.

258 MR. BLASIER:

They did this on their own? You are aware they did it, aren't you?

259 MR. MARTZ:

Yes, yes.

260 MR. BLASIER:

When did they do this validation study?

261 MS. CLARK:

Objection, hearsay.

262 THE COURT:

Overruled.

263 MR. MARTZ:

I don't know the specific time. I think it was before I had done any of my tests or it may have been about the same time. I really don't know, to be perfectly honest with you.

264 MR. BLASIER:

Was that validation study done in connection with this case?

265 MR. MARTZ:

I believe the way they got involved is they were going to determine whether or not EDTA could be detected in trace quantities or in bloodstains to differentiate preserved from non-preserved blood. They were asked to do this and they were going to devise a procedure which then could be given to a laboratory to do the analysis. When this was all happening, it was determined that we would also try at headquarters to do the analysis ourselves, so I took it upon myself to do some preliminary tests and determined that I could do EDTA analysis. Quantico's testing was done to determine whether or not a procedure could be developed to give to another laboratory to do the testing.

266 MR. BLASIER:

Can we put that down as a yes, that their validation study was for purposes of this case?

267 MS. CLARK:

Objection. That misstates the testimony.

268 MR. MARTZ:

Well, you would have to ask them.

269 THE COURT:

Overruled.

270 MR. BLASIER:

You didn't ask them?

271 MR. MARTZ:

Not specifically, no.

272 MR. BLASIER:

You weren't interested in any of the work they did validating this methodology that you are using?

273 MS. CLARK:

Objection, argumentative.

274 MR. MARTZ:

Well--

275 THE COURT:

Sustained.

276 MR. MARTZ:

It depends on--

277 THE COURT:

Wait. Sustained.

278 MR. MARTZ:

Oh.

279 MR. BLASIER:

What is the purpose of a validation study?

280 MR. MARTZ:

Well, I think I did my own validation study and I think the purpose of it--

281 MR. BLASIER:

Move to strike, nonresponsive.

282 THE COURT:

Sustained. Answer stricken.

283 MR. BLASIER:

What is the purpose of a validation study?

284 MR. MARTZ:

To determine whether or not a procedure works.

285 MR. BLASIER:

Is it your understanding that that is what your research people at Quantico did?

286 MR. MARTZ:

They produced something that they called a validation study. I know that, yes.

287 MR. BLASIER:

And is it your testimony that you never looked at it?

288 MR. MARTZ:

I never looked at it, no.

KEY QUOTE
289 MR. BLASIER:

Now, during the lunch break would you--could you review that for us because I want to ask you some questions about it?

290 MR. MARTZ:

Umm, I don't see any purpose for it, to be perfectly honest with you.

291 MR. BLASIER:

Well, let me show you 1269-A and B. And for the record, 1269-A is discovery page 8419 and 1269-B is 8422. Will you look at those. Are those chromatograms?

292 MR. MARTZ:

Yes, they are.

293 MR. BLASIER:

Do they appear to be generated by the FBI?

294 MR. MARTZ:

I would--I would not know that.

295 MR. BLASIER:

Is that format used by the FBI?

296 MR. MARTZ:

This is a format used by the Finnegan TSQ instrument.

297 MR. BLASIER:

Is that the format you use?

298 MR. MARTZ:

It is one that we have available at the FBI laboratory, yes.

299 MR. BLASIER:

Same format as on all your charts?

300 MR. MARTZ:

Umm, yes.

301 MR. BLASIER:

And let's assume hypothetically that tests were done to determine how efficient your method was of removing EDTA. Do you have that hypothetical in mind?

302 MR. MARTZ:

Okay.

303 MR. BLASIER:

How would you test that hypothesis?

304 MR. MARTZ:

Well, you would extract it and then run it against a known.

305 MR. BLASIER:

Does it appear that that is what those charts do?

306 MS. CLARK:

Objection, 721, your Honor.

307 THE COURT:

Overruled.

308 MS. CLARK:

Objection, hearsay.

309 THE COURT:

Sustained.

310 MR. BLASIER:

Can you check with your people at Quantico over the lunch hour to see whether they did that test and what they found?

311 MS. CLARK:

Objection, 721. He did not rely on that. Hearsay.

312 THE COURT:

Overruled.

313 MR. BLASIER:

Will you do that for me?

314 MR. MARTZ:

I don't know what they will be there. I can call--what exactly do you want me to find out?

315 THE COURT:

Why don't we confer with Agent Martz at the lunch hour.

316 MR. BLASIER:

Okay.

317 MR. BLASIER:

When the materials that you had put together were provided to the Prosecutors, is it your understanding that that validation study was provided as well?

318 MR. MARTZ:

Yes.

319 MR. BLASIER:

Then is it fair to say that you didn't do any studies yourself to determine whether your methods for extracting blood or EDTA was efficient?

320 MR. MARTZ:

I think I did. I think I did. On February the 8th I extracted. I was given two samples by someone in the laboratory; one with EDTA and one without, and I was very easily able to determine which stain contained the EDTA and which one didn't.

321 MR. BLASIER:

Your Honor, move to strike, nonresponsive.

322 THE COURT:

Overruled.

323 MR. BLASIER:

Did you ever run a test where you did an extraction and then you did a second extraction to see if you had picked up all the EDTA in the first extraction?

324 MR. MARTZ:

No.

325 MR. BLASIER:

Would you agree that if you didn't pick up all the EDTA in the first extraction, you are going to see less of it when you run the test?

326 MR. MARTZ:

Yes.

327 MR. BLASIER:

Have you done any tests at all to determine whether the age of a bloodstain affects your ability to extract it with water alone?

328 MR. MARTZ:

Yes.

329 MR. BLASIER:

And do you have an opinion on whether aged bloodstains can be extracted with the same efficiency with just water as new bloodstains?

330 MR. MARTZ:

I had conducted several tests on old blood and two from 1993 and I think the other one was from 1991. These were EDTA bloodstains. And I was convinced, based on the analysis that I did with those stains, that the age of the blood, at least over three or four years, had no effect in me determining whether or not the stains were from preserved or non-preserved blood.

331 MR. BLASIER:

Move to strike that all as nonresponsive.

332 THE COURT:

Sustained. The answer is stricken in its entirety.

333 MR. BLASIER:

Agent Martz--

334 THE COURT:

Agent Martz, would you listen carefully, please, to the question and answer the question that is directed to you, sir.

335 MR. BLASIER:

Did do you any tests to determine whether an old dried bloodstain, not blood from a tube, but a bloodstain that is older can be just as efficiently extracted from that stain as a new bloodstain that has been put on the stain and just dried for an hour or so, with the use of plain water?

336 MR. MARTZ:

Yes, I did. I took two bloodstains from 1993 that had been on material since 1993. I extracted those and I got similar results for EDTA as other blood that was freshly prepared. I got similar results.

337 MR. BLASIER:

Did you make any effort in that particular test--by the way, when did you do that? Saturday?

338 MR. MARTZ:

That was done last weekend.

339 MR. BLASIER:

Now, when you did that, did you make any effort to quantify the amount of blood that you were able to get out of that old blood stain?

340 MR. MARTZ:

No.

341 MR. BLASIER:

Do you have any other base of experience vis-à-vis old bloodstains versus new bloodstains in terms of how efficient just using water is at removing all the blood?

342 MR. MARTZ:

No.

343 MR. BLASIER:

Do you agree with Dr. Rieders that using an ammonia solution in water is a better way to make sure that you extract all the blood?

344 MR. MARTZ:

Well, I mean, are we talking about blood or EDTA?

345 MR. BLASIER:

Both. Let's talk both.

346 MR. MARTZ:

For EDTA I don't know, to be perfectly honest with you.

347 MR. BLASIER:

And you did no testing to find that--answer that question either, did you?

348 MR. MARTZ:

No, no.

349 MR. BLASIER:

I want to ask you about the gate. Did you perform any tests or to your knowledge did the--your lab in Quantico perform any tests to determine whether or not a bloodstain, an EDTA bloodstain, placed on a metal gate and left exposed to the outside for, let's say, hypothetically a day to three weeks, whether there would be any degradation or loss of EDTA?

350 MR. MARTZ:

No, I did not.

351 MR. BLASIER:

Did you ever make any effort to determine the type of paint that was on the back gate?

352 MR. MARTZ:

No, I didn't believe that it was necessary.

353 MR. BLASIER:

Paints have metals that tend to attract EDTA, don't they?

354 MR. MARTZ:

In my opinion the EDTA would stay in the bloodstain.

355 MR. BLASIER:

Paints have metals that EDTA likes, don't they, and is very attracted to them?

356 MR. MARTZ:

I think it would depend on the type of paint, yes.

357 MR. BLASIER:

Did you do any tests at all to determine whether the type of paint upon which a bloodstain was deposited would attract some of the EDTA and remove it from the blood?

358 MR. MARTZ:

Well, I used one particular paint that we had in the laboratory, a metal surface. I don't know exactly which type of paint it was, but I was able to place a bloodstain on a painted metal surface and effectively remove the EDTA.

359 MR. BLASIER:

What effort did you make to find out whether the paint you used bore any similarity to the back gate?

360 MR. MARTZ:

None.

361 MR. BLASIER:

Did you make any effort to find out whether there was any rust on the back gate where that bloodstain was deposited?

362 MR. MARTZ:

No. Again, I didn't feel it was necessary.

363 MR. BLASIER:

Does rust attract EDTA?

364 MR. MARTZ:

It--it could.

365 MR. BLASIER:

It is iron, isn't it?

366 MR. MARTZ:

Well, but iron exists in different states. That is iron oxide and I don't know the property of iron oxide for attacking EDTA.

367 MR. BLASIER:

EDTA loves iron, doesn't it?

368 MR. MARTZ:

In certain form, depending on the pH.

369 MR. BLASIER:

Did you make any effort to determine what other environmental things might--let me rephrase. Did you make any effort to determine whether there was any fertilizer that had been used in the area of the gate and may have gotten to the bloodstain?

370 MR. MARTZ:

No, no, I did not.

371 MR. BLASIER:

Do fertilizers contain chemicals that are attracted to EDTA or that EDTA is attracted to?

372 MR. MARTZ:

I don't really now how that is relevant, but I guess that they could.

373 MR. BLASIER:

Were you trying to, in your positive controls, design them in such a way that they mimicked as close as possible what you would have expected to find had EDTA blood been used and put on the back gate?

374 MR. MARTZ:

Well, I tied to do that to the best of what I had available and did that with the sock. I used the same sock. With the gatepost, I didn't have that gatepost. We are talking many months later when I got the samples. The gatepost is certainly in different condition now than it was then. I couldn't stain it on the same area of the gate. Based on the testing that I did, I didn't feel that it was necessary to duplicate exactly the conditions because EDTA is a very, very stable chemical.

375 MR. BLASIER:

Isn't it the purpose of a positive control to test the hypothesis--let's assume that EDTA blood was used under the conditions which these stains were deposited, preserved and collected and see what we find. Isn't that what a positive control is for?

376 MR. MARTZ:

The positive control is to determine whether or not you can identify the substance that you are looking for and the matrix that it is on.

377 MR. BLASIER:

Is one of the purposes of a positive control to try and simulate the hypothesis, let's assume that EDTA blood was used on these bloodstains and let's put it through the same type of conditions that the evidence was and see what we find at the end of the road?

378 MR. MARTZ:

Well, I mean you can't duplicate everything exactly all the time. What you try to do is to duplicate as much as possible and that is why I used a painted surface in the laboratory to duplicate the painted gate, to determine whether or not I could remove EDTA from a painted surface.

379 MR. BLASIER:

Your painted surface, what was that? What kind of metal was that?

KEY QUOTE
380 MR. MARTZ:

It was--I'm sure it was an iron. It was a can.

381 MR. BLASIER:

It was a can, wasn't it?

382 MR. MARTZ:

Yeah, it was a can.

383 MR. BLASIER:

Wasn't anything like a gate?

384 MS. CLARK:

Objection.

385 THE COURT:

Sustained.

386 MR. MARTZ:

Well--

387 THE COURT:

Sustained.

388 MR. MARTZ:

Okay.

389 MR. BLASIER:

Now, other than--by the way, when you painted your can, how long did you leave--I'm sorry, when you put the bloodstain on the can, how long did you leave it there before you swabbed it off?

390 MR. MARTZ:

Probably 45 minutes.

391 MR. BLASIER:

Did you make any effort to deposit a stain on that can and leave it for a period of one day to three weeks to see what you might find?

392 MR. MARTZ:

No, I did not.

393 MR. BLASIER:

Did you ever make any efforts to determine what the whether was from July--I'm sorry--from June 12th to July 3rd, the period of time when that bloodstain may have been on that gate?

394 MR. MARTZ:

No. I didn't feel that that was necessary for my determination.

395 MR. BLASIER:

Did you make any effort to determine whether that particular bloodstain had changed in terms of being weathered from one--from the time it was deposited until it was collected?

396 MR. MARTZ:

No. You got to remember here, this bloodstain has been identified as human blood. DNA is a very fragile chemical. EDTA is a very, very, very stable chemical. So I felt that if it could be determined that it was blood, that I would have no trouble determining the EDTA content.

397 MR. BLASIER:

Is your reason for not doing any of those things that I have been talking about is because you made assumptions that they wouldn't make any difference?

398 MR. MARTZ:

Well, I don't know that I necessarily call them--well, you can call them assumptions. It was based on some scientific information that I had that I based that on.

399 MR. BLASIER:

Was it based on any experimentation on your part at all?

400 MR. MARTZ:

Well, I think--I think it is in a way experiments that I performed over the last twenty years in the laboratory I think is based a lot on that.

401 MR. BLASIER:

Have you ever worked with--I think--didn't you say you had never worked with EDTA until this case?

402 MR. MARTZ:

Well, I have worked with chemicals that are similar and I know what the melting point and boiling points of EDTA is and its property and their solubility and there are certain assumptions that you can make.

403 MR. BLASIER:

Let's talk about the sock. Did you make any effort--let's assume that the sock was collected around June 13th, okay? And did you make any effort to determine how many times the sock had been examined under high-intensity lights or any other kind of lighting during the period of time June 13th until you got it?

404 MS. CLARK:

Objection, irrelevant.

405 THE COURT:

Overruled.

406 MR. MARTZ:

No. Again I didn't feel it was necessary. EDTA, when dried, is a very, very, very stable chemical. The FDA would not use it as a preservative if it wasn't stable. It is a very stable chemical.

407 MR. BLASIER:

Are you aware of any study anywhere that looks at the effect of light on EDTA in a dried bloodstain?

408 MS. CLARK:

Objection, your Honor.

409 THE COURT:

Overruled.

410 MR. MARTZ:

No.

411 MR. BLASIER:

Did you perform any such test?

412 MR. MARTZ:

Well, in a sense I did. I looked at bloodstains that were several years old.

413 MR. BLASIER:

Do you have any idea what the history of those bloodstains were in terms of how often they had been examined and under what conditions?

414 MR. MARTZ:

No, but I'm sure they were under various conditions.

415 MR. BLASIER:

How do you know that?

416 MR. MARTZ:

Well, it is part of the FBI's procedure to dry the bloodstains on the cloth. They were dried back in 1993 on the cloth.

417 MR. BLASIER:

Where did those stains come from?

418 MR. MARTZ:

It was a case that was submitted to the FBI laboratory.

419 MR. BLASIER:

Where did they come from?

420 MR. MARTZ:

From people.

421 MR. BLASIER:

In what form?

422 MR. MARTZ:

Liquid blood.

423 MR. BLASIER:

That were then made into strains?

424 MR. MARTZ:

That's correct.

425 MR. BLASIER:

So those weren't stains deposited on a surface like a gate or a sock at all, were they?

426 MR. MARTZ:

Well, I mean they were stains that we placed onto a fabric.

427 MR. BLASIER:

They weren't evidence stains from a crime scene of blood taken off of evidence, were they?

428 MR. MARTZ:

No.

429 MR. BLASIER:

Did you do any tests to determine whether the effects of sudden temperature change or what the effects might be on EDTA in the sock of sudden temperature changes?

430 MR. MARTZ:

No. Again, I didn't feel it was necessary. EDTA is a very stable chemical that will decompose I think at about 290 degrees centigrade. That it is a very hot temperature. It is a very stable chemical.

431 MR. BLASIER:

Are you aware of any studies that look at that question?

432 MR. MARTZ:

No.

433 MR. BLASIER:

So again, you are saying that you are making assumptions that it wouldn't make a difference, that is why you didn't check for it?

434 MR. MARTZ:

I'm making assumptions based on my twenty years of experience working with chemicals.

KEY QUOTE
435 MR. BLASIER:

Is one of the reasons you didn't do some of these things is that you were kind of rushed on this?

436 MR. MARTZ:

No. I believe that I was able to answer the question which was put to me and that was my sole objective, to answer the question, and I believe I was able to do that without doing all the things that have been mentioned.

437 MR. BLASIER:

Would you agree that you have had time, since your testing in February, to do some of these validation type studies that I have suggested?

438 MR. MARTZ:

Well, I mean, you must realize I'm in charge of a unit at the FBI laboratory. I'm presently now in charge of the section until we get a new section chief. I am wearing a lot of different hats, I'm working cases, I'm reviewing the work of over twenty people, and right now I am actually in charge of over 200 people. I am in charge of the whole scientific analysis section of the FBI laboratory in the interim, until we get a new section chief, so I do have a lot of responsibilities at the FBI laboratory. And I believed that I answered the question satisfactorily. I did not need to do any other testing. Since the other day I have performed a few more tests, but other than that, I didn't feel that any other testing was needed.

439 MR. BLASIER:

I take it from that answer that it is a time problem? It would take a lot of time?

440 MR. MARTZ:

Well, it is that plus necessary. Was it necessary for me to do any other testing to answer the question? In my opinion it was not.

441 MR. BLASIER:

What is the appropriate method if you are going to use mass spectrometry to quantify the amount in an unknown sample?

442 MR. MARTZ:

Well, there is many different ways.

443 MR. BLASIER:

What is the most accepted?

444 MR. MARTZ:

Well, I don't know of whether it is the most accepted, but to me the best way in mass spectrometry is to use what is called a deuterated standard and that is what we routinely use at the FBI laboratory for quantitation. It is a very expensive means of quantitation, but I believe it is most effective in mass spectrometry for precise quantitation.

445 MR. BLASIER:

Now, correct me if I am wrong. An internal standard, that is something that is very close to the EDTA, but you know it is there and you know how much is there, correct?

446 MR. MARTZ:

Correct.

447 MR. BLASIER:

And it is actually mixed in with the stain--with the liquid that you are going to look at, correct?

448 MR. MARTZ:

That's correct.

449 MR. BLASIER:

In other words, it is not run at one time and then your evidence is run at a second time?

450 MR. MARTZ:

Correct.

451 MR. BLASIER:

And the reason why you run them together is you can get this wide variation from one run to the next in terms of what comes out of the run, correct?

452 MR. MARTZ:

It determines on your definition of "Wide variation." There is a some variation, but it is acceptable.

453 MR. BLASIER:

You would agree on getting a four-fold difference on two things that are identical is not terribly precise, is it?

454 MR. MARTZ:

Not for precise quantitation, yes.

455 MR. BLASIER:

Okay. Now, we talked about whether you used an internal standard or not in Washington, did we not?

456 MR. MARTZ:

Yes, we did.

457 MR. BLASIER:

Do you remember what you told me about that?

458 MR. MARTZ:

Well, I told you I would have liked to use an internal standard and the deuterated standard is not available.

459 MR. BLASIER:

Actually you recall you told me that you would have loved to have one?

460 MR. MARTZ:

I would have loved to have one, then I wouldn't have had to answer so many questions.

461 MR. BLASIER:

Do you remember telling me it was the ultimate way to quantify?

462 MR. MARTZ:

That is the way that we prefer it at the FBI laboratory.

463 MR. BLASIER:

You didn't use an internal standard, did you?

464 MR. MARTZ:

Was not available.

465 MR. BLASIER:

You didn't use an internal standard, did you?

466 MR. MARTZ:

I did not use one because one was not available for the type of testing that I did.

467 MR. BLASIER:

What efforts did you--what effort did you do to try and find one?

468 MR. MARTZ:

I contacted the manufacturer of one of the largest radion of deuterated standards. They told me that it would be at least three months to develop it. It was a very expensive price also. The price didn't matter so much, but it was the time limit, but it would be at least three months to develop that standard for me or to make that standard.

469 MR. BLASIER:

Who is Cambridge?

470 MR. MARTZ:

That would be a company out of Canada that also makes deuterated standards.

471 MR. BLASIER:

Did you ever check with them?

472 MR. MARTZ:

No, I did not.

473 MR. BLASIER:

So you checked with one company?

474 MR. MARTZ:

I checked with the one that we generally do business with, which is one of the largest producers of the deuterated standards.

475 MR. BLASIER:

How many other companies are there that produce these kind of standards?

476 MR. MARTZ:

I don't know, to be perfectly honest.

477 MR. BLASIER:

Did you make any effort to find out any other companies that might have one?

478 MR. MARTZ:

I believe when I inquired with the one company I asked them if any other--if they knew of any other company that produced it and I believe their response was they didn't know of any other company.

479 THE COURT:

Mr. Blasier, about five minutes.

480 MR. BLASIER:

Five minutes?

481 THE COURT:

Five more minutes.

482 MR. BLASIER:

Okay.

483 (Brief pause.)
484 MR. BLASIER:

What is your understanding of a deuterated standard in terms of its cost?

485 MR. MARTZ:

Well, to have one developed is totally different than to buy one. Generally you can buy them for several hundred dollars, but to have one developed may be many, many, many thousands of dollars.

486 MR. BLASIER:

Would you agree if one were commercially available it certainly would be within the budget of the FBI?

487 MR. MARTZ:

Oh, sure, yes. Oh, sure.

488 MR. BLASIER:

Now, I want to ask you about your underlying data for the test that you did. Let's talk about the ones in February. I take it that these charts don't pop out of the machine, do they?

489 MR. MARTZ:

No. You have to--you have to request them or you actually tell the instrument to print out a particular chart.

490 MR. BLASIER:

Now, the data that is coming out of the machine, the raw data, what happens to that?

491 MR. MARTZ:

It is stored on a computer.

492 MR. BLASIER:

And it is stored on a computer for possible later analysis?

493 MR. MARTZ:

Well, generally what we do at the FBI laboratory is after the case is completed, we will erase the file, because we only have so much storage space, so after we have dictated the case, and all the review has been done, we will erase the files.

494 MR. BLASIER:

After you have completed the case? Now, where is the raw data that you did that formed the basis for all these charts right now?

495 MR. MARTZ:

It no longer exists. It was erased off the computer when the case was dictated.

496 MR. BLASIER:

It has been destroyed?

497 MR. MARTZ:

Well, yes.

498 MR. BLASIER:

Now, does the FBI in their computer system have what's called a back-up system?

499 MR. MARTZ:

Not for the--the instruments in the laboratory.

500 MR. BLASIER:

Now, did you assume that when you had dictated your report that you were done with this case?

501 MR. MARTZ:

I was--I was done with those analyses. I had made my opinion, a very careful opinion, and I was convinced of this and I--as far as I was concerned, I did not need to look at that data again. I had made my conclusions. I had printed out the appropriate charts and I would not need to see that data again.

502 MR. BLASIER:

Weren't you expecting that you would be called as a Prosecution witness up until the day they rested?

503 MS. CLARK:

Objection. That is irrelevant, your Honor.

504 THE COURT:

Sustained.

505 MR. BLASIER:

Wasn't your state of mind such that you knew or you anticipated that you would be called to testify by the Prosecution in this case?

506 MS. CLARK:

Objection, irrelevant.

507 THE COURT:

Sustained.

508 MR. BLASIER:

Did you know when the data was destroyed that this trial was still going on?

509 MS. CLARK:

Objection, irrelevant.

510 THE COURT:

Overruled.

511 MR. MARTZ:

Yes.

512 (Discussion held off the record between Defense counsel.)
513 MR. BLASIER:

Would you agree that without your underlying data there is no way that some other person can review that data?

514 MR. MARTZ:

Well, obviously in this case someone has reviewed it, so I don't know how I can agree with that.

515 MR. BLASIER:

I'm talking about the underlying data that forms the basis for the generation of these charts, the digital data?

516 MR. MARTZ:

Can you ask that question again?

517 MR. BLASIER:

Would you agree that the fact that you have destroyed the digital data, which is the underlying raw data for these tests, makes it impossible for anyone to review that digital data, anyone other than you? Even you can't review it?

518 MR. MARTZ:

I mean, I can't even review it. I mean, that data is gone. Nobody can review that data any more, but the charts that represent the digital data have been printed out and those can be reviewed.

519 MR. BLASIER:

Would you agree that there are different ways to analyze your digital data with this kind of a test, other than the charts you produced?

520 MR. MARTZ:

I don't know that I understand that question.

521 MR. BLASIER:

I'm sorry. Do you know whether there are other ways to analyze digital data that comes out of the machine other than by producing just this kind of chart?

522 MR. MARTZ:

Umm, I'm sure that there are, but you know, at the FBI laboratory what we do is trying to make identifications and for that we have certain charts that we point out that represent whether something is there or not and that is what we do all the time. Whether someone can do something else with that digital data, I don't know. It is not something that we do at the FBI laboratory.

523 MR. BLASIER:

Are you not familiar with the other methods that you can use with your Finnegan system to generate--using the raw data to generate--to do different kind of analysis?

524 MR. MARTZ:

Maybe if you could give me some specific--

525 (Discussion held off the record between Defense counsel.)
526 THE COURT:

All right. Mr. Blasier, we're going to take a break at this point.

527 MR. BLASIER:

I'm sorry?

528 THE COURT:

We are going to take a break. All right. Ladies and gentlemen, we are going to break for the noon hour. Please remember all my admonitions to you. Don't discuss the case among yourselves, form any opinions about the case, conduct any deliberations until the matter has been submitted to you or allow anybody to communicate with you with regard to the case. And Agent Martz, you are ordered to come back at 1:30. All right. We will be in recess until 1:30. All right. Let me see counsel without the court reporter, please.

529 (A conference was held at the bench, not reported.)
530 (The following proceedings were held in open court, out of the presence of the jury:)
531 (At 11:52 A.M. the noon recess was taken until 1:30 P.M. of the same day.)
532 (Appearances as heretofore noted.)
533 (Janet M. Moxham, CSR no. 4855, official reporter.)
534 (Christine M. Olson, CSR no. 2378, official reporter.)
535 (The following proceedings were held in open court, out of the presence of the jury:)
536 THE COURT:

All right. Back on the record in the Simpson matter. Mr. Simpson is again present with his counsel, People are represented. The jury is not present and Agent Martz is present. Counsel, anything we need to take up before we invite the jurors to rejoin us?

537 MR. BLASIER:

No.

538 THE COURT:

All right. Deputy Magnera, let's have the jurors, please. And, counsel, if you recollect, we will conclude today at 4:00 o'clock, at least as far as the jury is concerned. Then we have a number of legal arguments we can take up at 4:00 o'clock. And let me just ask as the jury is coming in, counsel, did both sides receive the letter from counsel at KNBC?

539 MR. COCHRAN:

We just got it. Yes, your Honor.

540 THE COURT:

All right. It may be germaine to our discussions.

541 (The following proceedings were held in open court, in the presence of the jury:)
542 THE COURT:

All right. Thank you, ladies and gentlemen. Please be seated. Agent Martz, would you resume the witness stand, please.

Roger Martz, the witness on the stand at the time of the lunch recess, resumed the stand and testified further as follows:

543 THE COURT:

All right. Good afternoon, Agent Martz.

544 MR. MARTZ:

Good afternoon.

545 THE COURT:

Agent Martz, you are reminded, sir, that you are still under oath. And, Mr. Blasier, you may continue with your direct examination.

546 MR. BLASIER:

Thank you, your Honor. Good afternoon, ladies and gentlemen.

THE JURY: Good afternoon.

DIRECT EXAMINATION BY MR. BLASIER

547 MR. BLASIER:

Agent Martz.

548 MR. MARTZ:

Good afternoon.

549 MR. BLASIER:

During the lunch break, did you have an opportunity to call your folks at Quantico regarding the question of whether your method of extraction allowed you to remove all the EDTA?

550 MR. MARTZ:

Yes, I did.

551 MR. BLASIER:

And did you find--did you make a determination as to whether--first of all, did they test your method?

552 MR. MARTZ:

Yes, they did.

553 MR. BLASIER:

And did they determine that your method was capable or allowed you to remove a hundred percent of the EDTA from the sample you were extracting?

554 MR. MARTZ:

They removed approximately 93 percent was the average.

555 MR. BLASIER:

So they determined that your method did not remove all the EDTA, correct?

556 MR. MARTZ:

That's correct.

557 MR. BLASIER:

I want to ask you a couple more questions about destroying your data. Did you indicate that your criteria for when it's okay to destroy the data was when you thought a case was over?

558 MR. MARTZ:

No. Once it's dictated.

559 MR. BLASIER:

Once it's dictated.

560 MR. MARTZ:

Once the case has been dictated and the report has left the laboratory.

561 MR. BLASIER:

Okay. How long after the report's left the laboratory in your mind is it okay to destroy the data?

562 MR. MARTZ:

Immediately.

563 MR. BLASIER:

Now, would you agree that using that standard, that never allows other scientists to review your data?

564 MR. MARTZ:

Well, I mean we provide the data like in this case, the printouts, but the electronic data is lost, yes.

565 MR. BLASIER:

And as part of your function as a criminalist, as an expert, you testify in cases and there are often times there are experts on other sides of the case, correct?

566 MR. MARTZ:

That's correct.

567 MR. BLASIER:

And is your understanding that it's common for one expert from one side of the case to look at the other expert's data to see if they made the right decision, right interpretations?

568 MR. MARTZ:

In the 20 years that I've been in the FBI laboratory, no one has ever asked to look at the digital data until now.

569 MR. BLASIER:

Did you find out from Quantico whether they saved their digital data?

570 MR. MARTZ:

Yes, they did.

571 MR. BLASIER:

Is it your understanding that--well, would you agree with this? It would be relatively easy for you to save your data if you wanted to?

572 MR. MARTZ:

Well, not relatively easy. There's only a limited amount of space on the hard drive, and once that that is full, then you have to find another means of saving that data. And I wouldn't agree that it's that easy. It's certainly not complicated, but it's something that we don't practice at the laboratory.

573 MR. BLASIER:

Well, there are tape back-up systems for the kind of computer you have that are very easy to attach and use, aren't there?

574 MR. MARTZ:

Well, I don't know about easy to attach and use. But they are available, yes. The deck equipment is quite complex and attachments. It's not like a simple, you know, PC home computer.

575 MR. BLASIER:

Now, do you accept that with that underlining digital data, you could do some additional things such as averaging spectra?

576 MR. MARTZ:

Yes.

577 MR. BLASIER:

And you could also do some further analysis by involving subtracting out background noise?

578 MR. MARTZ:

Yes.

579 MR. BLASIER:

And these are things that you can no longer do because your data is gone, correct?

580 MR. MARTZ:

Well, you can't do it on those data. You could always rerun the same samples or similar samples. There is bloodstain left in this particular case. If someone wanted to analyze that stain, they could certainly analyze it.

581 MR. BLASIER:

But as far as the tests that you're testifying about, that can't be done, can it?

582 MR. MARTZ:

No.

583 MR. BLASIER:

Now, you described to us how you made your positive control samples. And that's K67 and K68?

584 MR. MARTZ:

Those were the blood samples that I used to make my positive controls, yes.

585 MR. BLASIER:

And that was taken directly from the reference tubes of Mr. Simpson and Miss Simpson?

586 MR. MARTZ:

That's my understanding, yes.

587 MR. BLASIER:

Could you show me in your notes where you describe that process?

588 MR. MARTZ:

Right there and right there (Indicating).

589 MR. BLASIER:

Do your notes tell you how large a swatch you made?

590 MR. MARTZ:

No, they don't.

591 MR. BLASIER:

Now, I want to ask you some questions about the tests that you performed on your own blood. You have that in mind?

592 MR. MARTZ:

Yes.

593 MR. BLASIER:

Now, when did you do that test?

594 MR. MARTZ:

I believe the first one was April the 11th.

595 MR. BLASIER:

Do you have any records that you can check that?

596 MR. MARTZ:

Yes. I'm sorry. It's May 11th, 1995.

597 MR. BLASIER:

Did you make any notes describing how you did that experiment?

598 MR. MARTZ:

No, I did not.

599 MR. BLASIER:

You didn't write anything down, did you?

600 MR. MARTZ:

No.

601 MR. BLASIER:

Is it standard practice in your laboratory when you're performing tests like that that you don't write anything down?

602 MR. MARTZ:

Well, if you perform the test the same way you perform the other tests that are written, sometimes a person may or may not elect to write down the exact same thing that he wrote down before. In this particular case, I examined it the same way I had examined all the other samples and I did not write down how I did it.

603 MR. BLASIER:

So you performed these tests the same way that you did the other tests you've been testifying about?

604 MR. MARTZ:

Pretty much so. I made a cutting. I extracted with water, filtered, centrifuged and injected.

605 MR. BLASIER:

Well, you didn't use a bloodstain from evidence, did you?

606 MR. MARTZ:

No.

607 MR. BLASIER:

Describe to me how you got non-EDTA blood to use.

608 MR. MARTZ:

I went to the health service and I asked them to take two blood samples. I told them to take a non-EDTA sample first and then collect an EDTA sample. So they took a red stopper tube, collected blood and then took a purple stopper tube and collected blood.

609 MR. BLASIER:

Now, the red top tube, does that have any chemicals in it to preserve the blood?

610 MR. MARTZ:

I believe the one that they use was a serum collection tube, and I don't know if it did or not to be--I know it didn't have EDTA in it.

611 MR. BLASIER:

Do you know whether a red top tube has any kind of preservative in it at all?

612 MR. MARTZ:

No.

613 MR. BLASIER:

Now, from the point in time when you had your blood drawn into a red top tube, how long was it until you made a swatch?

614 MR. MARTZ:

I believe it was several days.

615 MR. BLASIER:

Do you have any information indicating that the bloodstains in this case were ever put in a red top tube and allowed to sit for several days?

616 MR. MARTZ:

No, I do not.

617 MR. BLASIER:

So would you agree that that particular set of conditions that you did isn't anything like the testing that you did of the evidence in this case?

618 MR. MARTZ:

No. I would disagree with that. EDTA is very soluble in blood, and in my opinion, it will be throughout the blood sample; and in preparing those samples, I don't believe that that would make a difference.

619 MR. BLASIER:

When you put this blood in a red top tube and let it sit for several days, where did it sit?

620 MR. MARTZ:

In the refrigerator at work.

621 MR. BLASIER:

And was it still blood when you got it out several days later?

622 MR. MARTZ:

Yes.

623 MR. BLASIER:

How long does it take blood to coagulate unpreserved?

624 MR. MARTZ:

Oh, I think about 5 minutes.

625 MR. BLASIER:

Did this blood coagulate at all?

626 MR. MARTZ:

Yes.

627 MR. BLASIER:

So it had been coagulating for five days?

628 MR. MARTZ:

It was a couple days, yes.

629 MR. BLASIER:

And sitting in the red top tube for five days?

630 MR. MARTZ:

That's correct.

631 MR. BLASIER:

Have any indication that the blood that was used on these stains was clotted blood?

632 MR. MARTZ:

No.

633 MR. BLASIER:

One of the compound--one of the things that EDTA is used in is rubber, correct?

634 MR. MARTZ:

I don't know that specifically, but I wouldn't--I would assume that it could be.

635 MR. BLASIER:

What's the stopper made out of on the red top tube that you had the blood in for several days?

636 MR. MARTZ:

Uh, I don't know to be perfectly honest with you.

637 MR. BLASIER:

Does it look like rubber?

638 MR. MARTZ:

It's either a rubber or synthetic rubber.

639 MR. BLASIER:

Is the inside of a red top tube coated with anything?

640 MR. MARTZ:

Uh, the red test tubes that were used had a chemical in them. I don't know what it was.

641 MR. BLASIER:

Silicon?

642 MR. MARTZ:

I don't know.

643 MR. BLASIER:

Do you know whether there's EDTA in silicon on the insides of blood tubes?

644 MR. MARTZ:

Uh, no, I do not.

645 MR. BLASIER:

Did you ever do any studies by putting plain water in a red top tube, letting it sit for several days and testing to see whether it had any EDTA in it?

646 MR. MARTZ:

No, I did not.

647 MR. BLASIER:

So is it fair to say that you do not know the answer to the question of whether or not the EDTA or what looked like EDTA that you found in your blood came from the tube itself?

648 MR. MARTZ:

Uh, I don't know that EDTA has ever been used in anything other than the purple top tube. Other than that, I don't have any information.

649 MR. BLASIER:

Okay. I'm not talking about EDTA as a preservative in a liquid form in the tube. I'm talking about the tube itself containing materials that have EDTA. Did you do any research at all to determine whether or not what you found in the blood came from the tube rather than you?

650 MR. MARTZ:

No.

651 MR. BLASIER:

Now, when you went back this weekend, you ran that sample again, didn't you?

652 MR. MARTZ:

Yes, I did.

653 MR. BLASIER:

And it had been sitting in--at that point, sitting in the red top tube for how long?

654 MR. MARTZ:

Well, since May, and then I analyzed it in July.

655 MR. BLASIER:

Okay.

656 MR. MARTZ:

May--

657 MR. BLASIER:

Was your purpose in running it again to determine whether you really had EDTA in your blood or not?

658 MR. MARTZ:

No. It was just to show the stability of EDTA over time.

659 MR. BLASIER:

So you weren't trying to determine whether you had EDTA in your blood when you did the second run?

660 MR. MARTZ:

The purpose of all of my experiments from the beginning, as I mentioned, were to determine whether or not the bloodstains were from preserved or nonpreserved blood and to differentiate between preserved and nonpreserved blood. I had--

661 THE COURT:

Excuse me. Agent Martz?

662 MR. MARTZ:

Yes, sir.

663 THE COURT:

The question was, the second run in July, what was the purpose of doing that, the second run?

664 MR. MARTZ:

To distinguish between preserved blood and nonpreserved blood to show that I can do that on blood that had aged for several months.

665 THE COURT:

Thank you.

666 MR. BLASIER:

What would be the best way--if you really wanted to test whether you had EDTA in your blood, what would be the best way to do that in your opinion?

667 MR. MARTZ:

I don't know about the best way. I'm sure that I do have EDTA in my blood. The question is how much I have in my blood, and to determine how much I have would depend on which instrumentation I would use, and I would probably want to take a larger volume of blood and somehow or another concentrate the EDTA for analysis.

668 MR. BLASIER:

Well, you would agree, would you not, that the amount of EDTA you would expect in your blood from your diet is in the parts per billion range?

669 MR. MARTZ:

I don't know that I could agree with that. I don't know that there's any data that substantiates that.

670 MR. BLASIER:

All of the studies that we've looked at that you've provided to us indicate that, don't they?

671 MR. MARTZ:

There was one study in 1954 and it had conflicting information.

672 MR. BLASIER:

By the way, the textbook that I mentioned to you--remember the authors' names?

673 MR. MARTZ:

Goodman and--Goodman and--I think I remember.

674 MR. BLASIER:

That's a 1994 textbook, isn't it?

675 MR. MARTZ:

But I believe in that particular case, they're referring back to the original study.

676 MR. BLASIER:

Well, it's a 1994 textbook, isn't it?

677 MS. CLARK:

Objection. This is argumentative.

678 THE COURT:

Sustained.

679 MR. BLASIER:

Is it a well-accepted current work of expertise in the area of pharmacology?

680 MR. MARTZ:

Well, I think what it has is references of the last work that was done in a particular area.

681 MR. BLASIER:

Is this a treaty--treatise that is used in pharmacology as a standard reference work?

682 MR. MARTZ:

It's a reference book, yes.

683 MR. BLASIER:

Do you know of any other reference work that contradicts that?

684 MR. MARTZ:

Yes. As I mentioned, in 1954, there was conflicting data in that paper.

685 MR. BLASIER:

That's the one paragraph we read?

686 MR. MARTZ:

Right.

687 MR. BLASIER:

Anything else?

688 MR. MARTZ:

I think there's been some other studies on ion EDTA and its absorption that may or may not conflict it.

689 MR. BLASIER:

Did you research that?

690 MR. MARTZ:

I can't remember the exact articles, but there possibly was some other conflicting data on ion EDTA.

691 MR. BLASIER:

When you researched this, did you attempt to find that kind of literature?

692 MR. MARTZ:

What I was trying to find in literature was how much EDTA would be present in a person.

693 MR. BLASIER:

Uh-huh.

694 MR. MARTZ:

And I could not satisfactory answer that question.

695 MR. BLASIER:

But one of the things you looked for is how much is absorbed, for instance, with iron, right?

696 MR. MARTZ:

Well one of the things that would be critical to determine that would be how much EDTA would be absorbed.

697 MR. BLASIER:

Those studies, the ones that you are referring to, can you give me the name of one of them?

698 MR. MARTZ:

Not right offhand.

699 MR. BLASIER:

Now, when you pulled together the literature to prepare for your testimony, is it fair to say that you tried to get the articles that were the most relevant to what you were going to testify about?

700 MR. MARTZ:

I tried to get most relevant articles on EDTA.

701 MR. BLASIER:

Okay. Now, by the way, where is the underlying data when you ran your own blood, the digital data?

702 MR. MARTZ:

It's been erased.

703 MR. BLASIER:

Did you ever write a report on testing your own blood?

704 MR. MARTZ:

No. It was not casework.

705 MR. BLASIER:

Then why did you destroy it before you dictated a report?

706 MR. MARTZ:

There was nothing to dictate. It was research that I had performed on my own blood.

707 MR. BLASIER:

Was it done for this case?

708 MR. MARTZ:

Yes.

709 MR. BLASIER:

Did you tell the Prosecution you were going to do it?

710 MR. MARTZ:

I don't believe I did.

711 MR. BLASIER:

Did you tell them after you did it what the results were?

712 MR. MARTZ:

I believe it was furnished to them at the same time it was furnished to you when you visited me on--about a week ago Tuesday.

713 MR. BLASIER:

So you never wrote--I'm sorry. Were you done?

714 MR. MARTZ:

Yeah. I never wrote a report.

715 MR. BLASIER:

Were you ever asked to conduct any kind of a study to determine taking other people than you, checking their blood directly rather than putting it in any kind of container to see if there's any EDTA?

716 MR. MARTZ:

No.

717 (Discussion held off the record between Defense counsel.)
718 MR. BLASIER:

Did the Prosecution ever ask you to test any of the samples, the other forensic samples in this case, bloodstains that may have come from Nicole brown Simpson, for instance, to see whether they showed EDTA?

719 MR. MARTZ:

No.

720 MR. BLASIER:

Did they ever ask you to check any stains in the area of stains collected in Chicago to determine whether there's any EDTA in Mr. Simpson's blood from those stains?

721 MR. MARTZ:

Not to my knowledge.

722 MS. CLARK:

Objection. Assumes facts not in evidence.

723 THE COURT:

Overruled.

724 MR. MARTZ:

Not to my knowledge.

725 MR. BLASIER:

Did they ever ask you to test any of the other evidence in this case to see if there was EDTA present?

726 MR. MARTZ:

Not to my knowledge.

727 MR. BLASIER:

That's all I have.

Temperature

tense

Key Quotes (5)

Roger Martz
I was just faxed another copy of another chromatogram that could possibly give similar results that I just got several minutes ago.
Reveals Martz received a last-minute alternative explanation for his EDTA-like findings right before testifying, suggesting the prosecution was scrambling to rebut the defense's EDTA-planting theory.
Roger Martz
I never looked at it, no.
Martz admits he never reviewed the Quantico validation study for the very methodology he used in this case, a damaging concession about the rigor of his analysis.
Robert Blasier
So you had made up your mind as to what you were going to find before you did the test?
Encapsulates the defense's core attack — that Martz conducted his testing backwards, starting with a conclusion and building toward it.
Roger Martz
I'm making assumptions based on my twenty years of experience working with chemicals.
Martz's fallback defense for dozens of untested variables, which Blasier systematically transforms into a liability rather than a credential.
Roger Martz
Your painted surface, what was that? What kind of metal was that? It was a can.
Blasier gets Martz to admit his positive control for the back gate — a metal gate outdoors for weeks — was a tin can with a 45-minute dried stain.

Evidence (4)

Q206 / Q207
Cuttings from the sock bearing blood stains, assigned FBI evidence numbers by Agent Doug Deedrick
Discussed — Blasier elicits that Martz combined both samples for his first test without knowing their precise origin within the sock
Informal
Back gate blood swatch — a small cotton swatch saturated with blood collected from the Rockingham rear gate
Discussed — Blasier challenges Martz's failure to quantify blood amount, examine the swatch microscopically, or account for how it was collected
Defense 1269-A and 1269-B
Chromatograms from the FBI Quantico lab's validation study of Martz's EDTA detection methodology, discovery pages 8419 and 8422
Introduced and discussed — Blasier uses them to confront Martz with a validation study he never read, suggesting the study tested extraction efficiency
Informal
Chromatogram of a steroid-type compound faxed to Martz during the proceedings as a possible alternative explanation for his EDTA-like ion findings
Discussed — Martz disclosed receiving it mid-testimony; Blasier established it used a different method (gas chromatography / electron impact) than Martz's technique

Notable Exchanges (5)

Robert BlasierRoger Martz
Blasier walks Martz through his choice to use the less-sensitive negative ion mode on day one, then the more sensitive positive ion mode on day two — but with half the sample. Martz insists sensitivity was not the issue, specificity was, but cannot explain why he used less sample with the more sensitive test.
strategic
Robert BlasierRoger Martz
Blasier establishes that Martz never validated whether his water extraction method efficiently removed all EDTA from a bloodstain — no second-extraction test, no comparison against ammonia solutions, no testing of aged stains from crime scenes. Martz repeatedly falls back on 'I didn't feel it was necessary.'
revealing
Robert BlasierRoger Martz
Martz admits his positive control for the back gate was a tin can with a 45-minute bloodstain, versus a metal gate outdoors exposed for potentially three weeks, and that he made no effort to match the paint, test for rust, or account for fertilizer or weather.
devastating
Lance A. ItoRoger Martz
Judge Ito repeatedly interrupts Martz mid-answer to redirect him to the actual question, sustaining multiple motions to strike Martz's nonresponsive answers — an unusual display of judicial control over a prosecution expert.
procedural
Robert BlasierRoger Martz
Blasier elicits that from February (when Martz first detected the EDTA-like ions) until the morning of testimony, Martz had not attempted to identify any other compound that could explain his positive findings — the alternative explanation arrived by fax that morning.
revealing

Light Moments (2)

Roger Martz
Martz interrupts himself mid-explanation to ask 'Can I continue answering the question?' — a small assertion of pushback against Blasier's tight control of the examination.
Roger Martz
When pressed on what his painted metal surface positive control actually was, Martz concedes: 'It was a can.' Blasier needs nothing more.

Credibility Attacks (4)

⚔ Roger Martz
methodological impeachment
Blasier systematically demonstrates that Martz's EDTA testing lacked validation: he never ran second extractions to confirm efficiency, never read the Quantico validation study, never tested aged crime-scene stains, used a tin can as a proxy for an outdoor iron gate, and relied on visual inspection rather than quantitative methods to assess blood concentration.
⚔ Roger Martz
bias / predetermined conclusion
Blasier challenges Martz's objectivity by showing he concluded EDTA was absent on day one using a less-sensitive test, then framed all subsequent positive findings as artifacts — suggesting he worked backward from a conclusion rather than following the evidence.
⚔ Roger Martz
prior inconsistent statement
Blasier confronts Martz with estimates Martz gave during a pre-trial meeting in Washington — including 2 microliters of blood from the gate and 50 microliters from the sock — which Martz cannot clearly recall or confirm, undermining confidence in his quantitative reasoning.
⚔ Roger Martz
omission / failure to investigate
Blasier elicits that Martz never reviewed the FBI's own Quantico validation study for his methodology, never investigated the paint type or rust on the actual back gate, and received an alternative explanation for his positive ion findings by fax the morning of his testimony.

Witness Demeanor

Martz frequently volunteers unsolicited explanations and context, requiring Judge Ito to intervene and instruct him to answer the question as directed.
Martz appears defensive and resistant to conceding methodological gaps, often responding to yes/no questions with lengthy justifications before Blasier moves to strike.
Martz acknowledges memory lapses about specific prior statements made to Blasier during their pre-trial meeting in Washington ('I can't remember that, but it would be at least...').

Objections

17 objections (9 sustained, 8 overruled)
Proceeding 7023 • 727 utterances • Defense witness
Criminal Trial
Department 103
⚖️ Start
📂 JUL 25, 1995 📄 Direct examination of Roger Ma
JUL 25, 1995 KRT DvH TD